查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612205

主動脈瘤市場：按類型、產品、治療、最終用途分類 - 全球預測 2025-2030

Aortic Aneurysm Market by Type (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), Product (Catheters, Stent Grafts), Treatment, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年主動脈瘤市值為44.3億美元，預計到2024年將達到47.9億美元，複合年成長率為8.65%，到2030年將達到79.2億美元。

主動脈瘤是主動脈的局部擴大，主動脈是將血液從心臟輸送到身體其他部位的主要動脈。主動脈診斷和治療市場受到心血管疾病盛行率上升和全球人口老化的推動，全球人口變得更容易罹患此類疾病。此外，先進影像處理技術和外科手術（例如血管內動脈瘤修復術（EVAR））的日益普及正在擴大醫院和專科診所的應用範圍和最終用途。市場成長主要由診斷工具的技術進步、早期檢測重要性的意識計劃以及政府措施推動。然而，主要挑戰包括治療費用高昂、貧困地區獲得醫療保健的機會有限以及對熟練醫療專業人員的需求。主要的成長機會包括開發更具成本效益的診斷解決方案和微創手術選擇，這可以減少復原時間和醫療成本，同時惠及更廣泛的人。創新是生物技術和資料分析的交叉點，研究重點是遺傳標記和人工智慧，以更準確地預測動脈瘤的形成和進展。開發人員應尋求與高科技公司合作，開發人工智慧診斷和個人化治療計劃。然而，應對監管複雜性至關重要，因為合規性可確保安全性和有效性標準。儘管存在這些障礙，市場仍可以從數位醫療服務的擴展中受益，該服務可以透過對主動脈瘤患者進行遠端監控和檢查來解決一些存取問題。總而言之，儘管主動脈瘤市場面臨高治療成本和監管挑戰等限制，但人工智慧和生物技術領域的重點研究和策略聯盟可以為 Masu 的重大進步鋪平道路。這種方法不僅有望改善患者的治療效果，而且使公司處於心血管醫療保健創新的前沿。

主要市場統計
基準年[2023] 44.3億美元
預測年份 [2024] 47.9億美元
預測年份 [2030] 79.2億美元
複合年成長率（%） 8.65%

市場動態：揭示快速發展的主動脈瘤市場的關鍵市場洞察

主動脈瘤市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 老化社會主動脈瘤發生率增加
    • 加強宣傳宣傳活動並定期篩檢高風險族群
  • 市場限制因素
    • 產品召回增加
  • 市場機會
    • 醫學影像和微創手術技術的進步
    • 醫療機構合作
  • 市場挑戰
    • 對主動脈瘤手術期間和術後併發症的擔憂

波特五力：主動脈瘤市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解主動脈瘤市場的外部影響

外部宏觀環境因素在塑造主動脈瘤市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解主動脈瘤市場的競爭狀況

主動脈瘤市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣主動脈瘤市場供應商績效評估

FPNV定位矩陣是評估主動脈瘤市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了主動脈瘤市場的成功之路

主動脈瘤市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老化社會主動脈瘤發生率增加
      • 加強宣傳宣傳活動並定期對高危險群進行檢測
    • 抑制因素
      • 產品回收數量增加
    • 機會
      • 醫學影像和微創手術技術的進步
      • 醫療機構間合作
    • 任務
      • 對主動脈瘤手術期間和術後併發症的擔憂
  • 市場區隔分析
    • 類型：腹主動脈瘤（AAA）在患有高血壓的老年人中越來越多。
    • 最終用途：醫院嚴重主動脈瘤管理和治療的演變
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章主動脈瘤市場：依類型

  • 腹部主動脈血管瘤
  • 胸主動脈瘤

第7章主動脈瘤市場：依產品

  • 導管
  • 血管支架

第8章主動脈瘤市場（依治療）

  • 動脈瘤血管內修復術
  • 透過開放性手術修復

第9章主動脈瘤市場：依最終用途分類

  • 門診手術中心
  • 診所
  • 醫院

第10章北美和南美的主動脈瘤市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太主動脈瘤市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的主動脈瘤市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 加州大學戴維斯分校健康中心開始地區首個使用創新微創主動脈裝置的臨床試驗
    • FDA核准用於先進治療的新型戈爾設備，宣布推出 TAMBE 內置假體消除設備
    • Nectero Medical 開始創新主動脈瘤治療的關鍵臨床試驗
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Altura Medical Inc.
  • Artivion, Inc.
  • Bentley InnoMed GmbH
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • Cardinal Health company
  • Cook Medical Inc.
  • CryoLife, Inc.
  • Endologix Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Lemaitre Vascular Inc.
  • LifeTech Scientific Corporation
  • LivaNova PLC
  • Lombard Medical, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Phenox GmbH
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-D1342F184FD2

The Aortic Aneurysm Market was valued at USD 4.43 billion in 2023, expected to reach USD 4.79 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 7.92 billion by 2030.

An aortic aneurysm is a localized enlargement of the aorta, the main artery carrying blood from the heart to the rest of the body. The market for its diagnosis and treatment is driven by the rising prevalence of cardiovascular diseases and an aging global population more susceptible to such conditions. Additionally, the increasing availability of advanced imaging technologies and surgical procedures, such as endovascular aneurysm repair (EVAR), expands the application and end-use scope across hospitals and specialty clinics. Market growth is primarily fueled by technological advancements in diagnostic tools, awareness programs about the importance of early detection, and government initiatives. However, the high costs associated with treatment, limited healthcare access in underprivileged regions, and the need for skilled healthcare professionals pose significant challenges. Key growth opportunities include the development of more cost-effective diagnostic solutions and minimally invasive surgical options, which would cater to a broader demographic while reducing recovery time and healthcare costs. Innovation lies at the intersection of biotechnology and data analytics, with research focused on genetic markers and artificial intelligence to predict aneurysm formation and progression more accurately. Businesses should explore partnerships with tech companies to develop AI-powered diagnostics and personalized treatment plans. However, navigating regulatory complexities is crucial, as compliance ensures safety and efficacy standards. Despite these hurdles, the market can benefit from expanding digital healthcare services, enabling remote monitoring and consultation for aortic aneurysm patients, thereby addressing some access issues. In conclusion, while the aortic aneurysm market faces limitations like high treatment costs and regulatory challenges, focused research and strategic collaborations in AI and biotechnology can pave the way for significant advancements. This approach not only promises better patient outcomes but also positions companies at the forefront of innovation in cardiovascular healthcare.

KEY MARKET STATISTICS
Base Year [2023] USD 4.43 billion
Estimated Year [2024] USD 4.79 billion
Forecast Year [2030] USD 7.92 billion
CAGR (%) 8.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aortic Aneurysm Market

The Aortic Aneurysm Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of aortic aneurysms among aging population
    • Rise in awareness campaigns and routine screenings for at-risk populations
  • Market Restraints
    • Rising incidences of product recalls
  • Market Opportunities
    • Advances in medical imaging technology and minimally invasive surgical techniques
    • Collaborations between medical institutions
  • Market Challenges
    • Concerns over complications during and after surgery of aortic aneurysms

Porter's Five Forces: A Strategic Tool for Navigating the Aortic Aneurysm Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aortic Aneurysm Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aortic Aneurysm Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aortic Aneurysm Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aortic Aneurysm Market

A detailed market share analysis in the Aortic Aneurysm Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aortic Aneurysm Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aortic Aneurysm Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aortic Aneurysm Market

A strategic analysis of the Aortic Aneurysm Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aortic Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Altura Medical Inc., Artivion, Inc., Bentley InnoMed GmbH, Bolton Medical, Inc., Boston Scientific Corporation, Cardinal Health company, Cook Medical Inc., CryoLife, Inc., Endologix Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lemaitre Vascular Inc., LifeTech Scientific Corporation, LivaNova PLC, Lombard Medical, Inc., Medtronic PLC, MicroPort Scientific Corporation, Phenox GmbH, Terumo Corporation, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Aortic Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm.
  • Based on Product, market is studied across Catheters and Stent Grafts.
  • Based on Treatment, market is studied across Endovascular Aneurysm Repair and Open Surgical Repair.
  • Based on End-use, market is studied across Ambulatory Surgery Centers, Clinic, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of aortic aneurysms among aging population
      • 5.1.1.2. Rise in awareness campaigns and routine screenings for at-risk populations
    • 5.1.2. Restraints
      • 5.1.2.1. Rising incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in medical imaging technology and minimally invasive surgical techniques
      • 5.1.3.2. Collaborations between medical institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over complications during and after surgery of aortic aneurysms
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing cases of abdominal aortic aneurysm (AAA) found in older individuals with high blood pressure
    • 5.2.2. End-use: Evolving management and treatment of severe cases of aortic aneurysms in the hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aortic Aneurysm Market, by Type

  • 6.1. Introduction
  • 6.2. Abdominal Aortic Aneurysm
  • 6.3. Thoracic Aortic Aneurysm

7. Aortic Aneurysm Market, by Product

  • 7.1. Introduction
  • 7.2. Catheters
  • 7.3. Stent Grafts

8. Aortic Aneurysm Market, by Treatment

  • 8.1. Introduction
  • 8.2. Endovascular Aneurysm Repair
  • 8.3. Open Surgical Repair

9. Aortic Aneurysm Market, by End-use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Clinic
  • 9.4. Hospitals

10. Americas Aortic Aneurysm Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Aortic Aneurysm Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Aortic Aneurysm Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. UC Davis Health Initiates Regional First in Clinical Trial Using Innovative, Less Invasive Aortic Device
    • 13.3.2. FDA Approves New Gore Device for Advanced Aortic Aneurysm Treatment, Introducing the Excluder TAMBE Endoprosthesis
    • 13.3.3. Nectero Medical Launches Pivotal Clinical Trial for Innovative Aortic Aneurysm Treatment
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Altura Medical Inc.
  • 3. Artivion, Inc.
  • 4. Bentley InnoMed GmbH
  • 5. Bolton Medical, Inc.
  • 6. Boston Scientific Corporation
  • 7. Cardinal Health company
  • 8. Cook Medical Inc.
  • 9. CryoLife, Inc.
  • 10. Endologix Inc.
  • 11. Johnson & Johnson Services, Inc.
  • 12. Koninklijke Philips N.V.
  • 13. Lemaitre Vascular Inc.
  • 14. LifeTech Scientific Corporation
  • 15. LivaNova PLC
  • 16. Lombard Medical, Inc.
  • 17. Medtronic PLC
  • 18. MicroPort Scientific Corporation
  • 19. Phenox GmbH
  • 20. Terumo Corporation
  • 21. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. AORTIC ANEURYSM MARKET RESEARCH PROCESS
  • FIGURE 2. AORTIC ANEURYSM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AORTIC ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AORTIC ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AORTIC ANEURYSM MARKET DYNAMICS
  • TABLE 7. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY STENT GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY ENDOVASCULAR ANEURYSM REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY OPEN SURGICAL REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AORTIC ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES AORTIC ANEURYSM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AORTIC ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM AORTIC ANEURYSM MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. AORTIC ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. AORTIC ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023